LncRNA 51325 Alleviates Bone Cancer Induced Hyperalgesia Through Inhibition of Pum2.
Yahui WangChengfei XuPeng LiuQiuli HeShihua ZhangZhihao LiuChaobo NiLiping ChenTong ZhiLongsheng XuLiang ChengXuewu LinMing YaoHuadong NiPublished in: Journal of pain research (2024)
Our findings indicate that lncRNA51325 plays a role in regulating bone cancer pain by inhibiting Pum2 expression, offering a promising avenue for novel treatments targeting nociceptive hypersensitivity induced by bone metastatic cancer.